Tumour blood flow for prediction of human prostate cancer aggressiveness: a study with Rubidium-82 PET, MRI and Na(+)/K(+)-ATPase-density

PURPOSE: Tumour blood flow (TBF) is a crucial determinant of cancer growth. Recently, we validated Rubidium-82 ((82)Rb) positron emission tomography (PET) for TBF measurement in prostate cancer (PCa) and found TBF and cancer aggressiveness positively correlated. The aims of the present study were to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Nucl Med Mol Imaging
Main Authors: Jochumsen, Mads Ryø, Sörensen, Jens, Pedersen, Bodil Ginnerup, Nyengaard, Jens Randel, Krag, Søren Rasmus Palmelund, Frøkiær, Jørgen, Borre, Michael, Bouchelouche, Kirsten, Tolbod, Lars Poulsen
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835182/
https://ncbi.nlm.nih.gov/pubmed/32808078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-04998-2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki